FY26-pharmacy march

Ended Awarded Last action

Contract number
15B50926F00000064
Awardee
Awarding agency
Obligated
$61,988

Award facts

Contract value 100% obligated
$61,988.37 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Titusville, Hopewell Township, NJ 08560, USA

Award details come from SAM.gov/FPDS.

About this award

Actelion Pharmaceuticals US, Inc. has been awarded a delivery order valued at $61,988.37 under the FY26 Pharmacy March procurement, with an ultimate completion date of March 31, 2026. This firm fixed-price delivery order was issued by the Federal Correctional Institution Fort Worth on March 1, 2026, with no small business set-aside designation. The contract represents a continuation of pharmaceutical supply services under Actelion's existing Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and Drugs, valued at $219.1 million and effective through July 31, 2029, which serves as the parent master vehicle enabling streamlined federal procurement of specialized pharmaceutical products across authorized agencies.

Actelion specializes in rare disease medications, with particular focus on pulmonary arterial hypertension treatments and related therapeutic interventions. The company supplies the Federal Bureau of Prisons and Federal Correctional Institutions with medications including Tracleer, Zavesca, Ventavis, Veletri, Opsumit, Uptravi, Opsynvi, Tyvaso, and Adempas through pre-negotiated pricing established under its indefinite delivery vehicles. Performance will occur at Actelion's facility in Titusville, New Jersey. As the prime contractor, Actelion executes delivery orders without subcontractor involvement, utilizing firm fixed-price arrangements that incorporate annual statutory pricing updates to fulfill ongoing pharmaceutical supply needs across federal correctional healthcare facilities.

Quick answers

Who was awarded contract 15B50926F00000064?

15B50926F00000064 was awarded to Actelion Pharmaceuticals US, Inc. by Federal Correctional Institution Fort Worth (Correctional Facilities) on March 1, 2026.

How much is contract 15B50926F00000064 worth?

The government has obligated $61,988 on 15B50926F00000064.

Is contract 15B50926F00000064 an order under another contract?

Yes. 15B50926F00000064 is a delivery order under 36F79724D0159, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 15B50926F00000064 competed?

The extent of competition for 15B50926F00000064 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award